Conventional and Real-Time PCR Targeting blaOXA Genes as Reliable Methods for a Rapid Detection of Carbapenem-Resistant Acinetobacter baumannii Clinical Strains
暂无分享,去创建一个
E. Gospodarek-Komkowska | A. Mikucka | Dagmara Depka | Mateusz Rzepka | Tomasz Bogiel | Patryk Zawadka
[1] E. Gospodarek-Komkowska,et al. An Application of Imipenem Discs or P. aeruginosa ATCC 27853 Reference Strain Increases Sensitivity of Carbapenem Inactivation Method for Non-Fermenting Gram-Negative Bacteria , 2021, Antibiotics.
[2] S. Joshi,et al. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital‐acquired infections: a scientific review , 2021, Journal of applied microbiology.
[3] A. Laudy,et al. Analysis of blaCHDL Genes and Insertion Sequences Related to Carbapenem Resistance in Acinetobacter baumannii Clinical Strains Isolated in Warsaw, Poland , 2021, International journal of molecular sciences.
[4] A. Nguyen,et al. Overexpression of blaOXA-58 Gene Driven by ISAba3 Is Associated with Imipenem Resistance in a Clinical Acinetobacter baumannii Isolate from Vietnam , 2020, bioRxiv.
[5] M. Wootton,et al. Rapid detection of OXA-23-like, OXA-24-like and OXA-58-like carbapenemases from Acinetobacter species by real-time PCR. , 2020, Journal of Hospital Infection.
[6] S. Songca,et al. Molecular Detection of Carbapenemase-Encoding Genes in Multidrug-Resistant Acinetobacter baumannii Clinical Isolates in South Africa , 2020, International journal of microbiology.
[7] R. Bonomo,et al. Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace , 2020, Biomolecules.
[8] Charles K. Cooper,et al. Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates , 2020, Journal of Clinical Microbiology.
[9] Woojun Park,et al. Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy , 2017, Journal of Microbiology.
[10] Gina K. Thomson,et al. High-Stringency Evaluation of the Automated BD Phoenix CPO Detect and Rapidec Carba NP Tests for Detection and Classification of Carbapenemases , 2017, Journal of Clinical Microbiology.
[11] W. Hryniewicz,et al. Evaluation of the Carba NP test for carbapenemase detection in Enterobacteriaceae, Pseudomonas spp. and Acinetobacter spp., and its practical use in the routine work of a national reference laboratory for susceptibility testing , 2017, European Journal of Clinical Microbiology & Infectious Diseases.
[12] K. Carroll,et al. Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli , 2017, Journal of Clinical Microbiology.
[13] Samyyia Abrar,et al. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan. , 2017, Microbial pathogenesis.
[14] ProticDragana,et al. Nosocomial Infections Caused by Acinetobacter baumannii: Are We Losing the Battle? , 2016 .
[15] M. Zdravković,et al. Nosocomial Infections Caused by Acinetobacter baumannii: Are We Losing the Battle? , 2016, Surgical infections.
[16] J. Smajlović,et al. Epidemiological Monitoring of Nosocomial Infections Caused by Acinetobacter Baumannii , 2014, Medical archives.
[17] Paolo Visca,et al. Acinetobacter baumannii: evolution of a global pathogen. , 2014, Pathogens and disease.
[18] S. Uzunović,et al. Carbapenemases in Gram-Negative Bacteria: Laboratory Detection and Clinical Significance , 2014, BioMed research international.
[19] P. Nordmann,et al. CarbAcineto NP Test for Rapid Detection of Carbapenemase-Producing Acinetobacter spp , 2014, Journal of Clinical Microbiology.
[20] A. Peleg,et al. Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies , 2013, Expert review of anti-infective therapy.
[21] Rui Wang,et al. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. , 2012, The Journal of antimicrobial chemotherapy.
[22] M. Iacono,et al. The genomics of Acinetobacter baumannii: Insights into genome plasticity, antimicrobial resistance and pathogenicity , 2011, IUBMB life.
[23] P. Nordmann,et al. Worldwide Dissemination of the blaOXA-23 Carbapenemase Gene of Acinetobacter baumannii1 , 2010, Emerging infectious diseases.
[24] P. Nordmann,et al. Diversity, Epidemiology, and Genetics of Class D β-Lactamases , 2009, Antimicrobial Agents and Chemotherapy.
[25] Harald Seifert,et al. Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.
[26] L. Dijkshoorn,et al. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.
[27] M. Kaufmann,et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. , 2006, FEMS microbiology letters.
[28] N. Woodford,et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. , 2006, International journal of antimicrobial agents.
[29] eazyplex SuperBug kits for detecting carbapenemase-producing organisms , 2022 .